News

AG decks the card aisle with LCD-enhanced cards

BY Rozanne Gelbinovich

CLEVELAND — American Greetings is decking card aisles with its LCD-enhanced cards, preloaded with Christmas images or ready to be customized with favorite photos. The four designs feature full-color LCD displays and high-quality audio.

American Greetings was the first to bring LCD technology to greeting cards last year. The patented innovation allows consumers to upload photos into a digital slideshow card. This year, the company has expanded its card selection.

The digital slideshow card can feature a maximum of 50 photos, which can be uploaded into the card through a self-contained 1-in. retractable USB cord and then will be brought to life on the 1.8-in. LCD screen. Instrumental music and the customized slideshow play automatically each time the card is opened. The card is rechargeable and requires no software installation.

Preloaded versions of the cards feature playful, multi-image slideshows set to music. For example, one card features a combination of pets in Santa hats set to barking and meowing renditions of "Deck the Halls," while another follows the story of two penguins building a snowman to the tune of "Jingle Bells."

"We’re so excited about our LCD cards and believe they will be the gift that gets passed around and bragged about at family gatherings," stated Carol Miller, executive director of new product concepts at American Greetings. "We can’t wait for consumers to experience them — both as the person who has fun sending the card and as the lucky recipient opening up the mailbox."

Both versions of the cards can be found at participating drug chains, grocery stores and mass retailers nationwide, as well as in American Greetings and Carlton Cards retail stores.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Supervalu to sell Total Logistic Control

BY DSN STAFF

MINNEAPOLIS — Supervalu on Wednesday announced that it has entered into a stock purchase agreement for the sale of Total Logistic Control — a wholly owned subsidiary that provides logistics and supply chain management solutions to manage distribution, warehousing and transportation operations for food, beverage and consumer packaged goods companies — to Ryder Integrated Logistics.

Subject to closing conditions and regulatory approvals, the sale is expected to close Dec. 31.

"TLC has been a strong and growing part of our supply chain services organization," stated Janel Haugarth, Supervalu EVP, president and COO of supply chain services. "Today’s announced acquisition of TLC by Ryder positions TLC to become part of a company that will take them to the next level of expansion and growth in their field of expertise servicing CPG companies. Supervalu will continue to focus its efforts on becoming America’s Neighborhood Grocer, and providing supply chain expertise and services to our independent and owned stores."

Additional details regarding the terms of the agreement were not disclosed.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Study shows 50% reduction of myeloma among patients

BY Alaric DeArment

ANN ARBOR, Mich. — A new three-drug combination may work as a front-line treatment for cancer of the plasma cells, according to an early-stage clinical study.

Researchers at the University of Michigan Comprehensive Cancer Center combined Onyx Pharmaceuticals’ drug carfilzomib with Celgene’s Revlimid (lenalidomide) and a low dose of dexamethasone in patients with myeloma. All participants in the study showed a reduction of their disease of at least 50%. Results of the study were presented Tuesday at the American Society of Hematology’s annual meeting.

“The combination treatment appears to deliver everything we expected and more,” Comprehensive Cancer Center multiple myeloma program director Andrzej Jakubowiak said in a statement. “We have seen no neurotoxicity and fantastic efficacy, the best reported to date.”

According to news reports, Onyx plans to file for regulatory approval of carfilzomib in the middle of next year.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?